{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:13:11Z","timestamp":1784729591665,"version":"3.55.0"},"reference-count":56,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["FI20\/00090"],"award-info":[{"award-number":["FI20\/00090"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cinitapride is a gastrointestinal prokinetic drug, prescribed for the treatment of functional dyspepsia, and as an adjuvant therapy for gastroesophageal reflux disease. In this study, we aimed to explore the impact of relevant variants in <jats:italic>CYP3A4<\/jats:italic> and <jats:italic>CYP2C8<\/jats:italic> and other pharmacogenes, along with demographic characteristics, on cinitapride pharmacokinetics and safety; and to evaluate the impact of <jats:italic>CYP2C8<\/jats:italic> alleles on the enzyme's function. Twenty\u2010five healthy volunteers participating in a bioequivalence clinical trial consented to participate in the study. Participants were genotyped for 56 variants in 19 genes, including cytochrome P450 (CYP) enzymes (e.g., CYP2C8 or CYP3A4) or transporters (e.g., SLC or ABC), among others. <jats:italic>CYP2C8<\/jats:italic>*3 carriers showed a reduction in AUC of 42% and C<jats:sub>max<\/jats:sub> of 35% compared to *1\/*1 subjects (<jats:italic>p\u2009=<\/jats:italic>\u00a00.003 and <jats:italic>p<\/jats:italic>\u00a0=\u20090.011, respectively). *4 allele carriers showed a 45% increase in AUC and 63% in C<jats:sub>max<\/jats:sub> compared to *1\/*1 subjects, although these differences did not reach statistical significance. <jats:italic>CYP2C8<\/jats:italic>*3 and *4 alleles may be used to infer the following pharmacogenetic phenotypes: ultrarapid (UM) (*3\/*3), rapid (RM) (*1\/*3), normal (NM) (*1\/*1), intermediate (IM) (*1\/*4), and poor (PM) metabolizers (*4\/*4). In this study, we properly characterized RMs, NMs, and IMs; however, additional studies are required to properly characterize UMs and PMs. These findings should be relevant with respect to cinitapride, but also to numerous CYP2C8 substrates such as imatinib, loperamide, montelukast, ibuprofen, paclitaxel, pioglitazone, repaglinide, or rosiglitazone.<\/jats:p>","DOI":"10.1111\/cts.13386","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:43:15Z","timestamp":1662453795000},"page":"2613-2624","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["<scp><i>CYP2C8<\/i><\/scp>*3 and *4 define <scp>CYP2C8<\/scp> phenotype: An approach with the substrate cinitapride"],"prefix":"10.1111","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3989-3910","authenticated-orcid":false,"given":"Diana Mar\u00eda","family":"Campod\u00f3nico","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-4320","authenticated-orcid":false,"given":"Pablo","family":"Zubiaur","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-2626","authenticated-orcid":false,"given":"Paula","family":"Soria\u2010Chacartegui","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-1130","authenticated-orcid":false,"given":"Ana","family":"Casaj\u00fas","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-3268","authenticated-orcid":false,"given":"Gonzalo","family":"Villapalos\u2010Garc\u00eda","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-6845","authenticated-orcid":false,"given":"Marcos","family":"Navares\u2010G\u00f3mez","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4245-7183","authenticated-orcid":false,"given":"Ant\u00eda","family":"G\u00f3mez\u2010Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3061-8659","authenticated-orcid":false,"given":"Ra\u00fal","family":"Parra\u2010Garc\u00e9s","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-7941","authenticated-orcid":false,"given":"Gina","family":"Mej\u00eda\u2010Abril","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7562-9845","authenticated-orcid":false,"given":"Manuel","family":"Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-7653","authenticated-orcid":false,"given":"Samuel","family":"Mart\u00edn\u2010V\u00edlchez","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1265-6600","authenticated-orcid":false,"given":"Dolores","family":"Ochoa","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-8885","authenticated-orcid":false,"given":"Francisco","family":"Abad\u2010Santos","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Instituto Te\u00f3filo Hernando Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Aut\u00f3noma de Madrid (UAM)  Madrid Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd) Instituto de Salud Carlos III  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12061"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62795-1"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30408-X"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16006"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2012.07.008"},{"key":"e_1_2_9_7_1","first-page":"717","article-title":"The prevalence of dyspepsia in Spain","volume":"103","author":"Caballero Plasencia AM","year":"1994","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_9_8_1","unstructured":"Spanish Drug Agency CIDINE 1 mg tablets \u2013 drug label.https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/58459\/FT_58459.html"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1447710"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_225_17"},{"key":"e_1_2_9_11_1","unstructured":"Drugs.com Cinitapride (ATCA03FA08).2022.https:\/\/www.drugs.com\/international\/cinitapride.html"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.010835"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0210"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01354-0"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0040603"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1842"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173772"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.2349\/biij.4.1.e5"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_2_9_20_1","unstructured":"European Medicines Agency Guideline on bioanalytical method validation (EMEA\/CHMP\/EWP\/192217\/2009).2011.https:\/\/www.ema.europa.eu\/en\/bioanalytical\u2010method\u2010validation"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802101-9.00018-1"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030204"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111087"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.718281"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1477"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2526"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1007"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.113"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.269"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.125"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2149"},{"key":"e_1_2_9_32_1","unstructured":"The Dutch Pharmacogenetics Working Group (DPWG) guidelines February 2022 update.https:\/\/www.knmp.nl\/media\/1058"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2016.06.012"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000070"},{"key":"e_1_2_9_35_1","first-page":"E94","article-title":"Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates","volume":"8","author":"Saiz\u2010Rodr\u00edguez M","year":"2020","journal-title":"Biomedicine"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm958"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283653b27"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.12.267"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03192303"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200110000-00006"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.82"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00228-5"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02592-5"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1830"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2021-0093"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.120239"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1409"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.891"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2010.487163"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.07.004"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0101"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13031"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112083"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119827959"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.78"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01414-x"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-018-0050-4"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.13386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:56:20Z","timestamp":1692633380000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.13386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1111\/cts.13386"],"URL":"https:\/\/doi.org\/10.1111\/cts.13386","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"2022-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}